NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that Moran Meiron Ph.D., Research Director, has been invited to present at the International Society for Stem Cell Research (ISSCR) on the “Mechanism of Action of Placental Derived Adherent Cells for the Treatment of Chronic Limb Ischemia”. This is the ISSCR 7th Annual Meeting and it will be held on July 8-11, 2009 at the Centre Convencions Internacional, Barcelona, Spain.
